● Recruiting

An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)

Condition: Non-segmental Vitiligo · Sponsor: Derm Texas, PLLC

PhasePhase 2

Planned participants20

Who can joinAll sexes, 2 Years to 18 Years

Healthy volunteersNo

About this study

An open-label single center, proof of concept study evaluating the efficacy of Roflumilast foam 0.3% in pediatric subjects with Non-Segmental Vitiligo (NSV)

This description comes directly from the study's public registry record.

Talk to the study team

Amanda Harvey, Study Coordinator · 2148456426 · aharvey@derm-texas.com

Always discuss trial participation with your own doctor first.

Locations (1)

Derm Texas

Dallas, Texas, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07105254